Background Essential mixed cryoglobulinemia is frequently associated with hepatitis C virus
(HCV) infection. A beneficial effect of interferon alfa therapy has been reported, but we do …

Mixed cryoglobulinemia (MC), type II and type III, refers to the presence of circulating
cryoprecipitable immune complexes in the serum and manifests clinically by a classical triad …

Background and aim Chronic HCV infection is associated with several extrahepatic
manifestations (EHMs). Data on the effect of sustained virological response (SVR) on the …

Cryoglobulins are present in about a quarter of patients with hepatitis C; in some,
cryoglobulinemia can become symptomatic or even life-threatening. This review …

Randomized trials have shown the enhancement of efficacy with interferon alfa‐2b and
ribavirin (IFN‐R) in comparison with interferon monotherapy (IFN) as first line treatment of …

Vasculitis can range in severity from a self-limited single-organ disorder to a life-threatening
disease with the prospect of multiple-organ failure. This condition presents many challenges …

Hepatitis C virus (HCV) has been associated with several extrahepatic conditions. To date,
most studies assessing these associations involved small numbers of patients and lacked a …

Hepatitis C Virus is associated with a wide series of extrahepatic manifestations. Based on
available data the link between the virus and some of these extrahepatic diseases is only …

Background: Several studies from Europe have reported a high prevalence (9% to 32%) of
chronic hepatitis C virus (HCV) infection in patients with B-cell non-Hodgkin lymphoma. It …

Immediate therapy comprised plasma exchange (14 sessions in 5 weeks), 100 mg/day
cyclophosphamide for 5 weeks, and 75 mg/day prednisone for one month, subsequently …